Health Canada and the FDA collaborate on generic drug information sharing initiative

Health Canada

1 December 2025 - Health Canada's Pharmaceutical Drugs Directorate and the US FDA Office of Generic Drugs have created a program to support the establishment of a request for information sharing program. 

This is a critical advancement in international collaboration. It falls under the framework of the generic drug cluster and through the confidentiality commitments established between Health Canada and FDA.

Read Health Canada press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Collaboration